Form 4: ICU Medical Director Equity Transaction Update
Statement of Changes in Beneficial Ownership
Director Kolleen T. Kennedy acquired 1,254 shares of ICU Medical common stock through the vesting of restricted stock units.
Summary
- Director Kolleen T. Kennedy exercised and vested 1,254 restricted stock units (RSUs) on May 13, 2026.
- The transaction resulted in the acquisition of 1,254 shares of common stock at a price of $0 per share.
- Following the transaction, the director holds a total of 4,539 shares of common stock.
- An additional grant of 1,475 restricted stock units was awarded to the director, vesting on May 13, 2027.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral, routine administrative filing regarding director equity compensation that does not signal a change in company strategy or financial health.
Positives
- Director maintains a direct ownership stake in the company, aligning interests with shareholders.
- The acquisition of shares through RSU vesting indicates ongoing compensation and retention of board leadership.
Negatives
- None identified; this is a routine equity compensation disclosure.
Risks
- None identified; this is a standard regulatory filing regarding director equity holdings.
Future Outlook
The filing indicates a future vesting event for 1,475 restricted stock units scheduled for May 13, 2027.
Industry Context
StockSavvy.ai notes that this filing represents standard corporate governance and executive compensation activity within the medical device sector, reflecting typical board member equity incentive structures.
Comparison to Industry Standards
- The use of restricted stock units for director compensation is consistent with standard practices for publicly traded companies in the healthcare sector.
- The reporting of these transactions via Form 4 complies with SEC requirements for timely disclosure of insider equity movements.
Stakeholder Impact
- Minimal impact on shareholders as this is a standard equity compensation event for a director.
Next Steps
- Vesting of 1,475 restricted stock units on May 13, 2027.
Key Dates
| Date | Description |
|---|---|
| 05/13/2026 | Date of RSU vesting and new RSU grant. |
| 05/13/2027 | Vesting date for the newly granted 1,475 restricted stock units. |
Keywords
ICU Medical, ICUI, Form 4, Insider Trading, Director Compensation, Restricted Stock Units
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.